PTCT

#2359
PTC Therapeutics, Inc. - Common Stock
73.8 5 USD
+3.94%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
73.85
73.85
년간 변동
44.17
87.50
일일 변동
+3.94%
월간 변동
+13.98%
6달 변화
-11.23%
년간 변동율
+50.99%
이전 종가
71.0 5
Open
73.8 5
저가
73.8 5
High
73.8 5
양
158
전체 차트 열기 Full chart

Financials

개요 성명 통계
4분기 연간
  • Market Capitalization 612.58 M
  • Employee 991
  • Founded 1998
  • CEO Matthew B. Klein
  • Website www.ptcbio.com
  • Headquarter Delaware, United States
  • FIGI BBG000QT15P7
  • Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
9.76
주가매출액비율
3.88

PTC Therapeutics, Inc. - Common Stock

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control mechanisms in orphan diseases. In September 2009, PTC entered into an agreement with Roche for the development of orally bioavailable small molecules for central nervous system diseases. PTC acquired the Bio-e platform in 2019.

뉴스